|Bid||17.10 x 800|
|Ask||0.00 x 900|
|Day's Range||21.60 - 22.03|
|52 Week Range||9.01 - 22.09|
|Beta (5Y Monthly)||0.74|
|PE Ratio (TTM)||N/A|
|Earnings Date||Feb 16, 2021 - Feb 22, 2021|
|Forward Dividend & Yield||0.20 (0.93%)|
|Ex-Dividend Date||Nov 27, 2020|
|1y Target Est||27.20|
TiVo®, the company that brings entertainment together and a wholly-owned subsidiary of Xperi Holding Corporation (Nasdaq: XPER) today announced that Cox Communications has entered into a multi-year extension of its intellectual property agreement for the company’s media-related patent portfolios.
Tessera Therapeutics, the Boston-based spin-up from Flagship Pioneering, is the latest company to enter the mix with $230 million in new financing to build up its platform for better biological programming. The round was led by Alaska Permanent Fund Corp., Altitude Life Science Ventures and the second SoftBank Vision Fund, with participation from the Qatari Investment Authority and other undisclosed investors. Last year, the company took the covers off its gene-writing service, which combined an array of different gene editing, manufacturing and synthesizing technologies to provide more tailored therapeutic instructions to genetic code.
We feel now is a pretty good time to analyse Xperi Holding Corporation's ( NASDAQ:XPER ) business as it appears the...